Human epididymis protein 4 indicates progression of cardiac fibrosis in Heart Failure with preserved Ejection Fraction

نویسندگان

چکیده

Abstract Background Cardiac fibrosis is one of the main causes diastolic dysfunction in heart failure with preserved ejection fraction (HFpEF). Human epididymis protein 4 (HE4) a novel pro-fibrotic expressed especially activated fibroblast, so-call myofibroblast [1]. Although our previous study showed that HE4 functioned as secretory factor promoting cardiac dilated cardiomyopathy [2], little known about role HFpEF. Purpose The aim this to evaluate pathophysiological HFpEF and association between serum levels clinical course Methods In basic research, we administered high-fat diet NOS inhibitor (L-NAME) mice for 5 weeks induce We analyzed echocardiographic findings mRNA expressions fibrosis-related genes including by real time PCR. measured 79 patients divided these into low high group using median values (102.0 pmol/L). Then, evaluated their mortality cardiovascular events retrospectively. Results vivo, administration fat L-NAME induced significant increase left ventricular mass on echocardiography compared control (p=0.006). aSMA collagen3a1 tissue was upregulated model (p=0.008 p=0.003, respectively). Furthermore, expression also (n=6) than (n=5), although differences did not reach statistical significance (p=0.238). vitro, recombinant genes, such periostin (p=0.001), (p=0.037), (p=0.095), PAI-1 (p=0.17), indicating facilitate activation fibroblast some significance. Kaplan-Meier curve revealed rate all cause death rehospitalization worsening were significantly higher group, suggesting can predicts prognosis Conclusion induces fibroblasts mice. it useful biomarker predicting Funding Acknowledgement Type funding sources: None.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Imaging fibrosis in heart failure with preserved ejection fraction

Increased myocardial fibrosis is considered to be a key underlying pathological mechanism in heart failure with preserved ejection fraction (HFpEF), with increased myocardial stiffness resulting in left ventricular dysfunction. Direct measurement of fibrosis via histology is not feasible; however, noninvasive imaging approaches now offer the potential for quantification. Improved fibrosis asses...

متن کامل

Heart Failure With Preserved Ejection Fraction

The Journal of the American Osteopathic Association July 2015 | Vol 115 | No. 7 432 From Henry Ford Wyandotte Downriver Cardiology in Brownstown, Michigan (Dr Rogers); West Suburban Medical Center in Oak Park, Illinois (Dr Gundala); Oakwood Southshore Medical Center in Trenton, Michigan (Dr Ramos); and Elmhurst Memorial Hospital in Illinois (Dr Serajian). Drs Gundala and Ramos are in their thir...

متن کامل

Heart Failure With Preserved Ejection Fraction

Symptomatic heart failure, despite preserved left ventricular (LV) ejection fraction, is a well-recognized phenomenon. This manifestation of diastolic dysfunction is associated with increased morbidity and mortality and can be attributed to a variety of pathogeneses, including diabetes mellitus, hypertension, infiltrative processes, and obesity. Unlike in systolic heart failure, where LV ejecti...

متن کامل

Heart Failure with Preserved Ejection Fraction

1. Demonstrate the association between heart failure with preserved ejection fraction (HFpEF) and survival. 2. Given a patient with heart failure (HF), recognize HFpEF on the basis of clinical signs and symptoms, physical examination, echocardiography, and radiographic findings. 3. Classify patients at high risk of hospitalization and mortality through assessing risk factors, clinical presentat...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: European Heart Journal

سال: 2022

ISSN: ['2634-3916']

DOI: https://doi.org/10.1093/eurheartj/ehac544.3011